Akebia Therapeutics, Inc.AKBANASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank77
5Y CAGR-2.5%
Studio
Year-over-Year Change

Year-over-year debt growth rate

5Y CAGR
-2.5%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202514.61%
202481.15%
20234.41%
2022-26.66%
20217.73%
202016.58%
2019622.15%
20180.00%
20170.00%
2016-100.00%